Xuejuan Wang
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K, Borkowski S, Reubi J, Maecke H. Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. Eur J Nucl Med Mol Imaging 2010; 38:97-107.
18.08.2010Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
18.08.2010Eur J Nucl Med Mol Imaging 2010; 38:97-107
Mansi Rosalba, Wang Xuejuan, Forrer Flavio, Waser Beatrice, Cescato Renzo, Graham Keith, Borkowski Sandra, Reubi Jean Claude, Maecke Helmut R
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides
Mansi R, Wang X, Forrer F, Kneifel S, Tamma M, Waser B, Cescato R, Reubi J, Maecke H. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides. Clin Cancer Res 2009; 15:5240-9.
11.08.2009Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides
11.08.2009Clin Cancer Res 2009; 15:5240-9
Mansi Rosalba, Wang Xuejuan, Forrer Flavio, Kneifel Stefan, Tamma Maria-Luisa, Waser Beatrice, Cescato Renzo, Reubi Jean Claude, Maecke Helmut R